The Scientist

» breast cancer

Most Recent

image: Pfizer to Buy Medivation for $14 Billion

Pfizer to Buy Medivation for $14 Billion

By | August 22, 2016

The pharma giant is purchasing the San Francisco–based cancer drugmaker to boost its oncology portfolio.

0 Comments

image: Esteemed Cancer Surgeon Dies

Esteemed Cancer Surgeon Dies

By | August 12, 2015

Carolyn Kaelin, a breast cancer surgeon, survivor, and advocate has passed away at age 54.

0 Comments

image: BRCA Breakthroughs?

BRCA Breakthroughs?

By | April 21, 2015

Color Genomics announces a new, lower-cost BRCA mutation test, while Inserm and Quest Diagnostics reveal plans to pool patient data to investigate rare mutations.

0 Comments

A National Cancer Institute model forecasts a marked increase in estrogen receptor-positive tumors among older women by 2030.

0 Comments

image: <em>BRCA</em> Mutations Mapped

BRCA Mutations Mapped

By | April 7, 2015

In a large study, researchers find evidence to suggest that the type and location of a woman’s BRCA1/2 mutations may affect her cancer risk.

0 Comments

image: Three Retractions for Highly Cited Author

Three Retractions for Highly Cited Author

By | March 19, 2015

Robert Weinberg’s team at MIT is pulling three papers, noting some figure panels were composites of different experiments.

4 Comments

image: Reduced Risk?

Reduced Risk?

By | October 22, 2014

A genome-wide association study identifies a SNP that could help explain the relatively low rates of breast cancer among Latina women.

0 Comments

image: Light’s Dark Side

Light’s Dark Side

By | July 25, 2014

Exposure to dim light at night speeds the growth of human breast cancer tumors implanted into rats and makes the cancer resistant to the drug tamoxifen.

6 Comments

image: A Multi-Cancer Diagnostic?

A Multi-Cancer Diagnostic?

By | July 14, 2014

Researchers report an ability to detect several types of cancer in blood samples based on signatures of immune response, but some are skeptical about the utility of such a test.

3 Comments

image: Cancer Research ROI

Cancer Research ROI

By | June 16, 2014

Report quantifies the returns from the U.K.’s investments in oncology.

2 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech